| Old Articles: <Older 49701-49710 Newer> |
|---|
 |
The Motley Fool
July 1, 2011
Brian Orelli |
What Will Cell Therapeutics Do With Your Money? Unfortunately the answer is probably, "buying a drug."   |
The Motley Fool
July 1, 2011
Seth Jayson |
Here's How Core Laboratories Is Making You So Much, So Fast With both 12-month and quarterly CCC running better than average, Core Laboratories gets high marks in this cash-conversion checkup. |
The Motley Fool
July 1, 2011
Seth Jayson |
How Long Does It Take to Make a Buck at Qualcomm? With quarterly CCC doing worse than average and the latest 12-month CCC coming in better, Qualcomm gets a mixed review in this cash-conversion checkup. |
The Motley Fool
July 1, 2011 |
AAR Earnings Preview AAR will unveil its latest earnings on Wednesday, July 6. |
The Motley Fool
July 1, 2011
David Williamson |
Dentsply Acquisition Delivers Smiles This smart deal makes money right off the bat. |
The Motley Fool
July 1, 2011
Jacob Roche |
Mr. Market Mistakes Good News for Bad What's going on with these fertilizer stocks? |
The Motley Fool
July 1, 2011
Rick Aristotle Munarriz |
5 Dates to Circle in July It's going to be a telltale month if you know what to look for in corporate earnings reports. |
The Motley Fool
July 1, 2011
Cindy Johnson |
5 Consumer Services Stocks Insiders Are Buying Open-market insider buys are a positive sign. |
The Motley Fool
July 1, 2011
Luke Timmerman |
Dendreon Sways Medicare to Pay for Prostate Cancer Drug The decision by Medicare is no surprise, but it does conclude a period of uncertainty about insurance reimbursement for its lone marketed product. |
The Motley Fool
July 1, 2011
Thomas Lee |
Mobile Apps Are Not Just for Smartphones; Ford Courts App Developers When you think about it, Ford's foray into mobile apps makes sense for both the car maker and app makers. |
| <Older 49701-49710 Newer> Return to current articles. |
